Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026

Denali Therapeutics Inc. announced it will report its Q2 2026 financial results and business highlights on Thursday, August 6, 2026. The report will be followed by a conference call and webcast hosted by Denali's management to discuss the results and provide a general business update. The biotechnology company focuses on developing biotherapeutics for neurodegenerative diseases and lysosomal storage disorders.